Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

1857 results about "Exosome" patented technology

Exosomes are extracellular vesicles (EVs) that are produced in the endosomal compartment of most eukaryotic cells. The multivesicular body (MVB) is an endosome defined by intraluminal vesicles (ILVs) that bud inward into the endosomal lumen. If the MVB fuses with the cell surface (the plasma membrane), these ILVs are released as exosomes. In multicellular organisms, exosomes and other EVs are present in tissues and can also be found in biological fluids including blood, urine, and cerebrospinal fluid. They are also released in vitro by cultured cells into their growth medium. Since the size of exosomes is limited by that of the parent MVB, exosomes are generally thought to be smaller than most other EVs, from about 30 to several hundred nanometres (nm) in diameter: around the same size as many lipoproteins but much smaller than cells. Compared with EVs in general, it is unclear whether exosomes have unique characteristics or functions or can be separated or distinguished effectively from other EVs. EVs including exosomes carry markers of cells of origin and have specialized functions in physiological processes, from coagulation and intercellular signalling to waste management. Consequently, there is a growing interest in clinical applications of EVs as biomarkers and therapies alike, prompting establishment of an International Society for Extracellular Vesicles (ISEV) and a scientific journal devoted to EVs, the Journal of Extracellular Vesicles.

Method for the preparation of purified HCV RNA by exosome separation

The invention relates to a method for the isolation of hepatitis C virus. The method comprises the separation of particles termed exosomes from the blood plasma of an individual infected with hepatitis C virus (HCV) and the extraction or RNA from these exosome particles.
Owner:GRIFOLS WORLDWIDE OPERATIONS +1

Stem cell exosome patch and preparation method and application thereof

InactiveCN104894062AAvoid the possibility of tumor formationStrong targetingImmobilised enzymesNervous system cellsBiological propertyAvailable drugs
The invention discloses a stem cell exosome patch and its preparation method and application and belongs to the field of tissue engineering. The stem cell exosome patch comprises the following steps: stem cell is cultured and stem cell exosome is collected; a patch scaffold is prepared; and the exosome obtained is attached to the patch scaffold to prepare the stem cell exosome patch. the stem cell exosome patch obtained has natural and easily available drug sources; action site accuracy of the exosome patch can be guaranteed; effective acting time of the patch after implantation can be prolonged; and potential safety hazard can be avoided to a great extent. Through the method, the stem cell exosome patch with good biological characteristics can be obtained. The invention is a new breakthrough of establishing a biological patch in the field of tissue engineering. Meanwhile, the product also provides a feasible scheme for clinical treatment of diseases. The principle of the invention is scientific and reliable, and the technology is simple and flexible.
Owner:JINAN UNIVERSITY

Exosome transfer of nucleic acids to cells

Methods for introducing nucleic acids to cells via exosomes for use in gene modulation and therapy, such as for gene silencing and to introduce genetic material into cells to compensate for abnormal genes or to induce or repress a process in the recipient cell.
Owner:CODIAK BIOSCI

Exosome inhibiting agents and uses thereof

The invention relates to methods and compositions for reducing exosome mediated tumor resistance against a therapeutic binding molecule and for increasing the efficacy of a therapeutic binding molecule suitable in the treatment of a disease. The methods include administering an effective amount of at least one agent inhibiting exosome formation and administering the therapeutic binding molecule.
Owner:WULF GERALD

Exosome carrier of targeted bone, CRISPR/Cas9 gene editing system and application

The invention relates to an exosome carrier of a targeted bone, a CRISPR / Cas9 gene editing system and application. The exosome carrier comprises a targeted peptide of any one of a targeted bone forming surface, a bone absorbing surface and an endothelial cell. The exosome carrier can be fused with (AspSerSer)6, (Asp)8 and a CREDVW oligopeptide respectively by transforming an exosome surface membrane protein lamp2b, so that an exosome can be fused with the targeted bone forming surface, the bone absorbing surface and the endothelial cell. Therefore, the bone targeting exosome is developed as the carrier, a CRISPR / Cas9 system serves as a gene editing and controlling tool, and the two parts are combined to play the important significance on the treatment of various bone diseases.
Owner:HOSPITAL OF STOMATOLOGY SUN YAT SEN UNIV

Method for separating exosome from human placenta-derived mesenchymal stem cell source and application thereof

The invention relates to a method for separating exosome from a human placenta-derived mesenchymal stem cell source. The method comprises the following steps: when the P2-P3 placenta-derived mesenchymal stem cell convergence rate reaches 85-90%, obtaining a cell culture supernate, carrying out membrane filtration, and collecting the filtrate; centrifugating the filtrate, collecting the centrifugal supernate, adding a 10w / v%-12w / v% polyethyleneglycol culture medium supernate solution into the centrifugal supernate according to the volume ratio of 1:1, sufficiently and uniformly mixing, and carrying out secondary centrifugation, wherein the finally obtained precipitate is the exosome. The method is convenient for taking materials, is easy for enrichment amplification culture, reutilizes the P2-P3 placenta-derived mesenchymal stem cell culture medium supernatant to obtain the exosome, and does not refer to the problem of medical ethics. In the exosome separation process, membrane filtration, centrifugation, polyethyleneglycol solution addition and other means are adopted to effectively increase the exosome enrichment, so the method has the advantages of short time consumption and low cost.
Owner:章毅 +7

Method for preparing exosome freeze-dried powder of human amniotic mesenchymal stem cells

The invention relates to the field of stem cells, discloses a method for preparing exosome freeze-dried powder of stem cells, and particularly relates to a method for preparing exosome freeze-dried powder of human amniotic mesenchymal stem cells. The method for preparing the exosome freeze-dried powder of the human amniotic mesenchymal stem cells disclosed by the invention comprises the following steps: mixing trehalose with exosomes of the human amniotic mesenchymal stem cells as a cryoprotectant; filtering and removing bacteria by virtue of a filter membrane; and firstly carrying out ultralow temperature pre-freezing, and then carrying out low-temperature freezing at a certain vacuum degree. The preparation method disclosed by the invention is simple to operate, safe and effective. An experiment proves that compared with a conventional preparation method of the freeze-dried powder, the morphologies and the activity of the exosomes of the human amniotic mesenchymal stem cells can be well kept by the method for preparing the exosome freeze-dried powder of the human amniotic mesenchymal stem cells disclosed by the invention; and the method is suitable for long-term preservation and application of the exosomes of the human amniotic mesenchymal stem cells.
Owner:GUANGZHOU SALIAI STEMCELL SCI & TECH CO LTD

Preparation and application of exosome secreted by human derived blood or mesenchymal stem cell

InactiveCN103767985AAvoid blocking, not easily absorbed by cellsProtection stabilityCosmetic preparationsSenses disorderStem cell cultureSomatic cell
The invention discloses preparation and application of exosome secreted by human derived blood or mesenchymal stem cell. The preparation process of exosome comprises: extracting mesenchymal stem cells from health-human body blood or a stem cell culture supernatant, performing in-vitro culture and amplification, and utilizing means such as low-temperature separation, purification and the like to prepare high-purity high-bioactivity exosome. The blood or mesenchymal stem cell secreted exosome is added into medicines, health-care products and cosmetics according to ratios for developing of products with bioactivity, is capable of effectively regulating and controlling body cell signal transduction, activating cell regeneration, enhancing health cell proliferation and differentiation capacity, further regulating physiologic restoration or removing damaged, pathologic and aged cells of a body, fundamentally changing body physiologic functions, and helping to generate anti-tumor treatment effect by adjusting cellular immunity. The blood or mesenchymal stem cell secreted exosome is applicable to fields of medical science, health care and beauty treatment, and has wide application prospect.
Owner:珠海霍普金斯医药研究院股份有限公司

Extracorporeal Removal of Microvesicular Particles

ActiveUS20090304677A1Effective and relatively benign treatmentEffective and relatively benignDialysis systemsSolid sorbent liquid separationSpecific immunityWilms' tumor
The invention described herein teaches methods of removing microvesicular particles, which include but are not limited to exosomes, from the systemic circulation of a subject in need thereof with the goal of reversing antigen-specific and antigen-nonspecific immune suppression. Said microvesicular particles could be generated by host cells that have been reprogrammed by neoplastic tissue, or the neoplastic tissue itself. Compositions of matter, medical devices, and novel utilities of existing medical devices are disclosed.
Owner:AETHLON MEDICAL INC

Application of exosome derived from human mesenchymal stem cells to resistance to tissue fibrosis and scar forming

The invention belongs to the technical field of molecular biology and relates to application of an exosome derived from human mesenchymal stem cells to preparation of medicines for antagonizing scars or tissue and organ fibrosis. According to the application, the high-purity and high-bioactivity exosome is obtained by subjecting healthy human umbilical cords to primary in-vitro culture, collecting liquid supernatant after amplification, performing low-temperature ultracentrifugation, purifying and the like; the exosome is used individually or added into medicines, health care products and cosmetics according to a proportion to be developed into a product with a bioactivity function, thereby being capable of regulating organism cell signal transduction effectively, inhibiting fibrocyte differentiation and then antagonizing the tissue and organ fibrosis and scar forming. Through experimental verification, the exosome can play a remarkable role in repairing promotion in hypertrophic scar after skin injury, particularly pathological fibrosis proliferation such as scar contracture of the joint parts, hepatic fibrosis and cardiac fibrosis, and is high in safety, little in toxicity and convenient to storage and transport, thereby being wide in application prospect.
Owner:SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY

MiRNA145-5p-modified umbilical cord mesenchymal stem cell exosome and preparation and application of miRNA145-5p-modified umbilical cord mesenchymal stem cell exosome

The invention belongs to the technical field of biology and particularly relates to a miRNA145-5p-modified umbilical cord mesenchymal stem cell exosome and preparation and application of the miRNA145-5p-modified umbilical cord mesenchymal stem cell exosome. The invention provides a preparation method of the highly-miRNA145-5p-expressed umsc-exosome (umbilical cord mesenchymal stem cell exosome) and application of various biological preparations for accelerating full-thickness skin defect healing and antagonizing scar contracture. The preparation method of the exosome includes (1), adopting fresh umbilical cords to culture human umbilical cord mesenchymal stem cells; (2) preparing mesenchymal stem cells highly expressed in miRNA145-5p; (3), storing conditional media; (4) performing exosome extraction and purification. The highly-miRNA145-5p-expressed umbilical cord mesenchymal stem cell exosome is transferred into a full-thickness wound model of rat backs by serving as a biological preparation, so that skin granulation tissue proliferation can be promoted effectively, wound healing is accelerated and scar contracture can be antagonized; novel approaches and novel methods are provided for wound treatment.
Owner:SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY

Use of human amniotic mesenchymal stem cell exosome

The invention relates to the field of stem cells, and discloses novel use of a stem cell exosome, and particularly discloses novel use of a human amniotic mesenchymal stem cell exosome. The experiment result shows that a human amniotic mesenchymal stem cell is capable of promoting growth of HDF cells, improving the activity of SOD (Superoxide Dismutase) enzyme in the cells, reducing attacks and damages to the cells caused by oxygen radicals generated by ultraviolet radiation induction, and reducing the death rate of the cells. The use shows that the human amniotic mesenchymal stem cell exosome has an anti-photoaging effect, and meanwhile, the human amniotic mesenchymal stem cell exosome is free of phototoxicity, so that application of the human amniotic mesenchymal stem cell exosome in preparation of an anti-ageing preparation is provided. The invention also provides an anti-ageing preparation of the human amniotic mesenchymal stem cell exosome.
Owner:GUANGZHOU SALIAI STEMCELL SCI & TECH CO LTD

Human umbilical cordmesenchymal stem cell-derived exosome and application thereof

ActiveCN101890050ASimple technical solution for preparationEasy to operateDigestive systemSkeletal/connective tissue cellsDiseaseLiver and kidney
The invention relates to extraction of an active ingredient exosome from a human umbilical cordmesenchymal stem cell and application thereof in preparation of medicaments for treating liver and kidney injury and skin diseases. The human umbilical cordmesenchymal stem cell-derived exosome is prepared by the following steps of: (1) culturing a human umbilical cordmesenchymal stem cell; (2) preparing a cordmesenchymal stem cell conditioned medium; and (3) separating and purifying the exosome. The experiments for infusing the human umbilical cordmesenchymal stem cell exosome serving as a medicament into a mice acute liver injury model, a rat kidney injury model and a rat skin scald model show that the medicament can improve the liver function, the kidney function and the skin condition, promote the pathological recovery of the liver, the kidney and the skin, reduce the death rate, fulfill the aims of blocking and reversing the development of the liver and kidney injury and open up a new approach for clinical treating of the liver and kidney injury.
Owner:江苏澳洋生物医药研究院有限责任公司

Exosome, preparing method of exosome and application of exosome in preparing medicine or preparation for treating sepsis

The invention discloses application of an exosome coming from umbilical cord mesenchymal stem cells optimized with interleukin-1beta (IL-1beta) in treating sepsis. Specifically, recombined IL-1beta of human is used for optimizing the umbilical cord mesenchymal stem cells to enhance the immunosupression function of the umbilical cord mesenchymal stem cells, and the exosome generated by the umbilical cord mesenchymal stem cells is extracted and used for treating sepsis. The exosome can effectively relieve the symptoms of sepsis, and increase the survival rate of mice suffering from sepsis; besides, the exosome has the advantages of being convenient to preserve and transport, and thus a new strategy is provided for treating diseases related to refractory inflammation such as sepsis.
Owner:NANJING UNIV

Human umbilical cord mesenchymal stem cell exosome type external cream and preparation method thereof

The invention provides human umbilical cord mesenchymal stem cell exosome type external cream and a preparation method thereof, and aims at the solving the problem in effectively inducing human umbilical cord mesenchymal stem cells to massively synthesize and secrete mesenchymal stem cell exosome capable of specifically promoting epidermis cell and hypodermal cell to proliferate, divide and differentiate, promoting the formation of collagenous fibers, reticular fibers and elastic fibers, and adjusting the secreting functions of collagen and mucopolysaccharide. The cream comprises human umbilical cord mesenchymal stem cell exosome extracting liquid and a base cream formula based on the mass ratio ranging from (1:20) to (3:10), wherein the human umbilical cord mesenchymal stem cell exosome extracting liquid is prepared by performing hungry culture on P2-P5 generations of human umbilical cord mesenchymal stem cells and stimulating through epidermal growth factors. The prepared cream has the effects of improving the skin quality, resisting the aging of skin cells, recovering the normal structure and physiological function of the skin, reducing the skin atrophy exsiccosis, and moisturizing the skin tissue.
Owner:南京九圣生物医学科技股份有限公司

Extracorporeal removal of microvesicular particles

ActiveUS8288172B2Effective and relatively benignDialysis systemsSolid sorbent liquid separationAntigenNeoplastic tissue
The invention described herein teaches methods of removing microvesicular particles, which include but are not limited to exosomes, from the systemic circulation of a subject in need thereof with the goal of reversing antigen-specific and antigen-nonspecific immune suppression. Said microvesicular particles could be generated by host cells that have been reprogrammed by neoplastic tissue, or the neoplastic tissue itself. Compositions of matter, medical devices, and novel utilities of existing medical devices are disclosed.
Owner:AETHLON MEDICAL INC

Method for promoting human bone mesenchymal stem cell proliferation based on exosome

The invention relates to the field of biotechnology and mainly relates to a use of an early-generation human umbilical cord mesenchymal stem cell exosome in promotion of human bone mesenchymal stem cell growth. The use method is a method for promoting bone mesenchymal stem cell growth. The invention also relates to an extraction method of a human umbilical cord mesenchymal stem cell exosome. The early-generation human umbilical cord mesenchymal stem cell exosome and human bone mesenchymal stem cells are co-cultured so that human bone mesenchymal stem cell growth is obviously promoted, cell doubling time is shortened and a ratio of an S period in a cell period is increased.
Owner:SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY

Method and a Kit To Detect Malignant Tumors and Provide a Prognosis

A method and kit is provided to quantifying and qualifying exosomes in human cell derived samples or in body fluid based on expression of TM9-superfamily proteins on the exosomes. Furthermore, a method and a kit to diagnose malignant tumors is provided. The disclosure also provides a method to monitor tumor growth.
Owner:EXOSOMICS SIENA SPA

Method for preparing human umbilical cord mesenchymal stem cell exosomes

The invention discloses a method for preparing human umbilical cord mesenchymal stem cell exosomes. The method uses a newborn umbilical cord as a source of umbilical cord mesenchymal stem cells, usesa medium prepared by a fetal calf serum or a serum substitute in which exosome carried by itself is removedfor culturing, collects a supernatant, and further separates and extracts the exosomesby differential centrifugation, the purity is high, and the source of the umbilical cord mesenchymal stem cell exosomes is ensured; the exosomes is prepared by the differential centrifugation, the operationis simple, and the method is suitable for large-scale production; during the whole process, sterility is guaranteed, the contamination ofmycoplasma is prevented, and the product safety is higher.
Owner:JINAN PANSHENG BIOTECH

Antibacterial and antitumor application of NK cell exosome and related miRNA

The invention discloses antibacterial and antitumor application of exosomes secreted by NK cells (aNK) activated by transmembrane IL-21 and multiple miRNAs contained in the exosomes, and provides a new method for bacterial infection and antitumor treatment. The method has the advantages that 1, the method is different from antibiotic treatment, and exosome antibiosis has lower side effects; 2, effects of antibacterial treatment can be enhanced through joint use; 3, the exosomes can be stored at low temperature, the miRNAs can be artificially synthesized, costs are low and large-scale production can be achieved; 4, the exosomes and the multiple miRNAs have inhibitory effects on a variety of bacteria, and have wider antibacterial spectra; 5, the miRNAs act on a variety of shared signal pathways of tumor cells, can inhibit a variety of tumors, and have a wide range of antitumor application.
Owner:ZHEJIANG UNIV +1

Method for separating exosome from human umbilical cord mesenchymal stem cell source and reagent used by method

The invention relates to a method for separating exosome from a human umbilical cord mesenchymal stem cell source and a reagent used by the method. The method comprises the following steps: (1) cultivating umbilical cord mesenchymal stem cells; and (2) extracting umbilical cord blood MSC exosome, wherein the umbilical cord mesenchymal stem cells are cultivated to P3 generation; and extraction forthe umbilical cord blood MSC exosome comprises the following steps: pre-treating exosome suspension; and extracting exosome. The reagent used by the method realtes to a solution which has a special formula and is used as a buffer pad. The method has the excellent technical effects as described in the specification.
Owner:FIVE DIMENSION BY INCOSC HEALTH MANAGEMENT JIANGSU

Exosome isolation

Methods of isolating exosomes from a biological sample is provided. In one embodiment, the method may include a series of optional centrifugation steps, and comprises exosome precipitation using a PEG-based solution followed by resuspension in a saccharide-based solution such as trehalose. The method advantageously results in essentially pure exosomes that maintain integrity and stability. The exosomes are useful for the in vivo delivery of cargo, including macromolecules such as protein and nucleic acid.
Owner:EXERKINE

Adipose tissue source exosome gel, preparation method and application

ActiveCN106676065AAvoid time consumingAvoid potential malignant cancer and other disadvantagesArtificial cell constructsSkeletal/connective tissue cellsNude mouseExosome
The invention belongs to the technical field of tissue engineering and particularly relates to adipose tissue source exosome gel, a preparation method and application. The adipose tissue source exosome gel is characterized by comprising an adipose tissue exosome and a solvent in a mass-volume ratio of (1-3):1, wherein an aquogel is served as the solvent. The preparation method comprises the following steps: treating an adipose tissue, acquiring an adipose tissue extract, acquiring the adipose tissue source exosome and preparing the adipose tissue source exosome gel. The adipose tissue source exosome gel is mainly used for promoting the fat regeneration. The invention particularly relates to the exosome extracted from the adipose tissue. When the exosome is applied to the nude mouse body, a new mature adipose tissue can be generated. The defects of insufficient seed cell resource, potential malignant transformation and tumor formation of the traditional tissue engineering can be overcome; the exosome has the advantage of easiness in storage and transportation; a new thought is supplied for acquiring the fat for the tissue engineering.
Owner:成都世联康健生物科技有限公司

Preparation method of gel containing stem cell exosomes for repairing skin wounds

The invention relates to a preparation method of a gel containing stem cell exosomes for repairing skin wounds. The method comprises the following steps: 1) primary extraction and culture of human umbilical cord mesenchymal stem cells: 1.1) primary extraction of human umbilical cord mesenchymal stem cells, 1.2) subculture, and 1.3) collection of the culture supernatant; 2) extraction of human umbilical cord mesenchymal stem cell exosomes: 2.1) primary centrifugation, 2.2) secondary centrifugation, 2.3) removal of organelles by centrifugation, 2.4) coarse extraction of exosomes, and 2.5) finalextraction of exosomes; 3) preparation of a gel material: 3.1) preparation of chitosan, 3.2) configuration of beta-glycerol phosphate (beta-GP), and 3.3) preparation of the gel material; and 4) gel loading of the exosomes. The gel containing stem cell exosomes can promote repair of skin wounds, shorten the healing time of wounds and reduce scar formation.
Owner:陕西朗泰生物科技有限公司

Extraction method of specific mesenchymal stem cell exosome

The invention discloses an extraction method of a specific mesenchymal stem cell exosome. The method comprises the following steps: collecting supernatant of serum-free mesenchymal stem cells: firstly, culturing mesenchymal stem cells, changing a culture medium for culturing, centrifuging, and removing cell debrises to obtain initial supernatant; taking the initial supernatant for carrying out further gradient centrifugation, transferring the centrifuged supernatant into a sterile centrifugal tube, centrifuging and collecting supernatant containing micro vesicles; centrifuging the supernatantcontaining the micro vesicles to obtain precipitate containing an exosome, washing and then centrifuging to obtain exosome precipitate; adding the obtained exosome precipitate into sterile PBS and filtering to obtain the specific mesenchymal stem cell exosome. The exosome collected in the extraction method disclosed by the invention adopts a filter membrane for filtration, so the extracted exosomeis enabled to be nanoscale; meanwhile, the rotational speed is reduced and optimized, high-speed mechanical damage is reduced, separation efficiency is high and the cost is low.
Owner:深圳市浊安认证生物技术有限公司

Exosome derived from human pluripotent stem cells, preparation based on exosome and use of exosome and preparation

The invention relates to an exosome derived from human pluripotent stem cells, a preparation based on the exosome and use of the exosome and preparation, and belongs to the technical fields of cell biology, molecular biology and drug research and development. The human pluripotent stem cell exosome or the preparation based on the human pluripotent stem cell exosome has the uses of A, being an additive cultured in vitro for maintaining the stemness of adult stem cells and inhibiting the senility of the adult stem cells; B, being an additive cultured in vitro for maintaining the proliferative activity of various tissue primary culture cells; C, being applied in preparing medicine for treating bone and cartilage degenerative changes; D, being applied in preparing medicine for preventing the bone and cartilage degenerative changes; E, being applied in preparing medicine for treating orthopedic diseases such as osteonecrosis, bone nonunion, fractures, cartilage injuries, tendon injuries, frozen shoulders or tendon adhesion. Compared with the prior art, the exosome secreted by the pluripotent stem cells has powerful functions of promoting tissue cell regeneration, preventing senility andtreating bone diseases.
Owner:上海睿泰生物科技股份有限公司

Preparing method and application of human mesenchymal stem cell-sourced exosome beautifying preparation

InactiveCN108721200APrecise regulation of immune statusRepair the traces of timeCosmetic preparationsToilet preparationsCuticleFreeze-drying
The invention discloses a preparing method and application of a human mesenchymal stem cell-sourced exosome beautifying preparation. The beautifying preparation comprises 92-108 parts of human umbilical cord mesenchymal stem cell exosome, 8-13 parts of mannitol, 0.42-0.55 part of oligopeptide-32, 1.3-2.5 parts of tetrapeptide-4, 0.7-1.3 parts of palmitoyl tripeptide-1 and 0.8-1.2 parts of palmitoyl pentapeptide-4. The preparation method includes: evenly mixing and stirring the human mesenchymal stem cell exosome, the mannitol, the oligopeptide-32, the tetrapeptide-4, the palmitoyl tripeptide-1and the palmitoyl pentapeptide-4 according to the weight, filtering through a filter membrane, performing split charging, and performing freeze drying to obtain the human mesenchymal stem cell-sourced exosome beautifying preparation. The exosome beautifying preparation can be externally applied to the epidermal layer or guided into an epidermis deep layer and the corium layer through a microneedle, a rolling needle or a hydro-lifting needle. The ImmuReg technology is utilized to bring the optimal repairing effect of freeze-dried powder into play, the skin immune state can be precisely adjusted, and accordingly aged cells can be removed, and skin cells can be rejuvenated.
Owner:成都赛伊泰生物科技有限公司

Application of exosome to preparing of acute-hepatic-failure treating medicine and medicine composition

The invention provides an application of exosome to preparing of acute-hepatic-failure treating medicine. The exosome is an exosome secreted through personal-menstrual-blood mesenchymal stem cells. The invention further provides a medicine composition, wherein the medicine composition comprises the exosome secreted through the personal-menstrual-blood mesenchymal stem cells and carriers acceptable in pharmacy. According to the medicine composition in the technical scheme, the survival time of an acute-hepatic-failure animal model can be prolonged, the bleeding rate and the necrotic rate of the livers can be decreased, and secreting of inflammatory factors through liver cells can be promoted, so that acute hepatic failure is effectively treated, and prognosis of an acute-hepatic-failure patient is improved accordingly.
Owner:ZHEJIANG SHENGCHUANG PRECISION MEDICAL TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products